APO Research
Talk to an analyst

APO RESEARCH · REPORT

SARS-Cov-2 Vaccine (Vero Cell)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global SARS-Cov-2 Vaccine (Vero Cell) Market Analysis and Forecast 2026-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchSARS-Cov-2 Vaccine (Vero Cell) Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal SARS-Cov-2 Vaccine (Vero Cell) Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal SARS-Cov-2 Vaccine (Vero Cell) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SARS-Cov-2 Vaccine (Vero Cell) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal SARS-Cov-2 Vaccine (Vero Cell) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global SARS-Cov-2 Vaccine (Vero Cell) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for SARS-Cov-2 Vaccine (Vero Cell) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for SARS-Cov-2 Vaccine (Vero Cell) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for SARS-Cov-2 Vaccine (Vero Cell) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for SARS-Cov-2 Vaccine (Vero Cell) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of SARS-Cov-2 Vaccine (Vero Cell) include Sinopharm, Pfizer, WIBP, Sinovac Biotech, IMBCAMS,China and BIBP, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for SARS-Cov-2 Vaccine (Vero Cell), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of SARS-Cov-2 Vaccine (Vero Cell), also provides the sales of main regions and countries. Of the upcoming market potential for SARS-Cov-2 Vaccine (Vero Cell), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the SARS-Cov-2 Vaccine (Vero Cell) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global SARS-Cov-2 Vaccine (Vero Cell) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for SARS-Cov-2 Vaccine (Vero Cell) sales, projected growth trends, production technology, application and end-user industry.

SARS-Cov-2 Vaccine (Vero Cell) Segment by Company

Sinopharm

Pfizer

WIBP

Sinovac Biotech

IMBCAMS,China

BIBP

SARS-Cov-2 Vaccine (Vero Cell) Segment by Type

Subunit Vaccine

Whole Virus Inactivated Vaccine

Split Vaccine

Others

SARS-Cov-2 Vaccine (Vero Cell) Segment by Application

Special Population

General Population

SARS-Cov-2 Vaccine (Vero Cell) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SARS-Cov-2 Vaccine (Vero Cell) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SARS-Cov-2 Vaccine (Vero Cell) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SARS-Cov-2 Vaccine (Vero Cell).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of SARS-Cov-2 Vaccine (Vero Cell) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of SARS-Cov-2 Vaccine (Vero Cell) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SARS-Cov-2 Vaccine (Vero Cell) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Subunit Vaccine Major Manufacturers Table 3. Whole Virus Inactivated Vaccine Major Manufacturers Table 4. Split Vaccine Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Special Population Major Manufacturers Table 8. General Population Major Manufacturers Table 9. SARS-Cov-2 Vaccine (Vero Cell) Industry Trends Table 10. SARS-Cov-2 Vaccine (Vero Cell) Industry Drivers Table 11. SARS-Cov-2 Vaccine (Vero Cell) Industry Opportunities and Challenges Table 12. SARS-Cov-2 Vaccine (Vero Cell) Industry Restraints Table 13. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2021-2026) Table 17. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2027-2032) Table 18. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2021-2026) & (K Units) Table 20. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2027-2032) & (K Units) Table 21. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2021-2026) Table 22. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2027-2032) Table 23. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Manufacturers (2021-2026) Table 27. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global SARS-Cov-2 Vaccine (Vero Cell) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global SARS-Cov-2 Vaccine (Vero Cell) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global SARS-Cov-2 Vaccine (Vero Cell) Manufacturers, Product Type & Application Table 31. Global SARS-Cov-2 Vaccine (Vero Cell) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global SARS-Cov-2 Vaccine (Vero Cell) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2021-2026) Table 38. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2027-2032) Table 39. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 41. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2027-2032) & (K Units) Table 42. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2021-2026) Table 43. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2027-2032) Table 44. Global SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2021-2026) & (US$/Unit) Table 45. Global SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2027-2032) & (US$/Unit) Table 46. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2021-2026) Table 50. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2027-2032) Table 51. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 53. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2027-2032) & (K Units) Table 54. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2021-2026) Table 55. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2027-2032) Table 56. Global SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2021-2026) & (US$/Unit) Table 57. Global SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2027-2032) & (US$/Unit) Table 58. Sinopharm Company Information Table 59. Sinopharm Business Overview Table 60. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 62. Sinopharm Recent Development Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 67. Pfizer Recent Development Table 68. WIBP Company Information Table 69. WIBP Business Overview Table 70. WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 72. WIBP Recent Development Table 73. Sinovac Biotech Company Information Table 74. Sinovac Biotech Business Overview Table 75. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 77. Sinovac Biotech Recent Development Table 78. IMBCAMS,China Company Information Table 79. IMBCAMS,China Business Overview Table 80. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 82. IMBCAMS,China Recent Development Table 83. BIBP Company Information Table 84. BIBP Business Overview Table 85. BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 87. BIBP Recent Development Table 88. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 89. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 90. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 91. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2027-2032) & (K Units) Table 92. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Type (2021-2026) & (US$/Unit) Table 93. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Type (2027-2032) & (US$/Unit) Table 94. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 95. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 96. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 97. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2027-2032) & (K Units) Table 98. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Application (2021-2026) & (US$/Unit) Table 99. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Application (2027-2032) & (US$/Unit) Table 100. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026) & (K Units) Table 105. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2027-2032) & (K Units) Table 106. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Country (2021-2026) & (US$/Unit) Table 107. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Country (2027-2032) & (US$/Unit) Table 108. United States SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 109. Canada SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 110. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 113. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2027-2032) & (K Units) Table 114. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Type (2021-2026) & (US$/Unit) Table 115. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Type (2027-2032) & (US$/Unit) Table 116. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 119. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2027-2032) & (K Units) Table 120. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Application (2021-2026) & (US$/Unit) Table 121. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Application (2027-2032) & (US$/Unit) Table 122. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 126. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026) & (K Units) Table 127. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2027-2032) & (K Units) Table 128. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Country (2021-2026) & (US$/Unit) Table 129. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Country (2027-2032) & (US$/Unit) Table 130. Germany SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 131. France SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 132. U.K. SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 133. Italy SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 134. Netherlands SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 135. China SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 136. China SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 137. China SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 138. China SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2027-2032) & (K Units) Table 139. China SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 142. China SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 143. China SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 144. China SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2027-2032) & (K Units) Table 145. China SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 150. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2027-2032) & (K Units) Table 151. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 156. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2027-2032) & (K Units) Table 157. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026) & (K Units) Table 164. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2027-2032) & (K Units) Table 165. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 168. South Korea SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 169. India SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 170. Australia SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 171. China Taiwan SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 173. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 176. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2027-2032) & (K Units) Table 177. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 182. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2027-2032) & (K Units) Table 183. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 189. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026) & (K Units) Table 190. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2027-2032) & (K Units) Table 191. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 194. Argentina SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 195. Chile SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 196. Colombia SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 197. Peru SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 199. Israel SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 200. UAE SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 201. Turkey SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 202. Iran SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 203. Egypt SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. SARS-Cov-2 Vaccine (Vero Cell) Distributors List Table 207. SARS-Cov-2 Vaccine (Vero Cell) Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. SARS-Cov-2 Vaccine (Vero Cell) Image Figure 2. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Subunit Vaccine Image Figure 5. Whole Virus Inactivated Vaccine Image Figure 6. Split Vaccine Image Figure 7. Others Image Figure 8. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Share 2021 VS 2025 VS 2032 Figure 10. Special Population Image Figure 11. General Population Image Figure 12. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Figure 14. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2021-2032) Figure 17. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (2021-2032) & (K Units) Figure 18. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico SARS-Cov-2 Vaccine (Vero Cell) Sales YoY (2021-2032) & (K Units) Figure 21. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales YoY (2021-2032) & (K Units) Figure 22. China SARS-Cov-2 Vaccine (Vero Cell) Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) SARS-Cov-2 Vaccine (Vero Cell) Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales YoY (2021-2032) & (K Units) Figure 25. Global SARS-Cov-2 Vaccine (Vero Cell) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global SARS-Cov-2 Vaccine (Vero Cell) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2021-2032) Figure 31. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2021-2032) Figure 34. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2021-2032) Figure 37. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2021-2032) Figure 40. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Type (2021-2032) Figure 41. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Type (2021-2032) Figure 42. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Application (2021-2032) Figure 43. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Application (2021-2032) Figure 44. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Country (2021-2032) Figure 45. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Country (2021-2032) Figure 46. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Type (2021-2032) Figure 47. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Type (2021-2032) Figure 48. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Application (2021-2032) Figure 49. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Application (2021-2032) Figure 50. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Country (2021-2032) Figure 51. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Country (2021-2032) Figure 52. China SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Type (2021-2032) Figure 53. China SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Type (2021-2032) Figure 54. China SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Application (2021-2032) Figure 55. China SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Application (2021-2032) Figure 56. Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Type (2021-2032) Figure 57. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Type (2021-2032) Figure 58. Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Application (2021-2032) Figure 59. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Application (2021-2032) Figure 60. Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Country (2021-2032) Figure 61. Asia SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Country (2021-2032) Figure 62. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Type (2021-2032) Figure 63. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Type (2021-2032) Figure 64. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Application (2021-2032) Figure 65. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Application (2021-2032) Figure 66. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Country (2021-2032) Figure 67. SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Country (2021-2032) Figure 68. SARS-Cov-2 Vaccine (Vero Cell) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. SARS-Cov-2 Vaccine (Vero Cell) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Subunit Vaccine
  • Whole Virus Inactivated Vaccine
  • Split Vaccine
  • Others
Applications
  • Special Population
  • General Population
Companies covered
  • Sinopharm
  • Pfizer
  • WIBP
  • Sinovac Biotech
  • IMBCAMS,China
  • BIBP

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 SARS-Cov-2 Vaccine (Vero Cell) Market by Type
  3. 1.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Subunit Vaccine
  5. 1.2.3 Whole Virus Inactivated Vaccine
  6. 1.2.4 Split Vaccine
  7. 1.2.5 Others
  8. 1.3 SARS-Cov-2 Vaccine (Vero Cell) Market by Application
  9. 1.3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Special Population
  11. 1.3.3 General Population
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 SARS-Cov-2 Vaccine (Vero Cell) Market Dynamics
  1. 2.1 SARS-Cov-2 Vaccine (Vero Cell) Industry Trends
  2. 2.2 SARS-Cov-2 Vaccine (Vero Cell) Industry Drivers
  3. 2.3 SARS-Cov-2 Vaccine (Vero Cell) Industry Opportunities and Challenges
  4. 2.4 SARS-Cov-2 Vaccine (Vero Cell) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region
  3. 3.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2021-2026)
  5. 3.2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2027-2032)
  6. 3.2.4 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region
  9. 3.4.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2021-2026)
  11. 3.4.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2027-2032)
  12. 3.4.4 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Manufacturers
  2. 4.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global SARS-Cov-2 Vaccine (Vero Cell) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Manufacturers
  6. 4.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global SARS-Cov-2 Vaccine (Vero Cell) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global SARS-Cov-2 Vaccine (Vero Cell) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global SARS-Cov-2 Vaccine (Vero Cell) Manufacturers, Product Type & Application
  13. 4.7 Global SARS-Cov-2 Vaccine (Vero Cell) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market CR5 and HHI
  16. 4.8.2 2025 SARS-Cov-2 Vaccine (Vero Cell) Tier 1, Tier 2, and Tier 3
5 SARS-Cov-2 Vaccine (Vero Cell) Market by Type
  1. 5.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type
  2. 5.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type
  6. 5.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2021-2032)
  9. 5.3 Global SARS-Cov-2 Vaccine (Vero Cell) Price by Type
6 SARS-Cov-2 Vaccine (Vero Cell) Market by Application
  1. 6.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application
  2. 6.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application
  6. 6.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2021-2032)
  9. 6.3 Global SARS-Cov-2 Vaccine (Vero Cell) Price by Application
7 Company Profiles
  1. 7.1 Sinopharm
  2. 7.1.1 Sinopharm Company Information
  3. 7.1.2 Sinopharm Business Overview
  4. 7.1.3 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  6. 7.1.5 Sinopharm Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 WIBP
  14. 7.3.1 WIBP Company Information
  15. 7.3.2 WIBP Business Overview
  16. 7.3.3 WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  18. 7.3.5 WIBP Recent Developments
  19. 7.4 Sinovac Biotech
  20. 7.4.1 Sinovac Biotech Company Information
  21. 7.4.2 Sinovac Biotech Business Overview
  22. 7.4.3 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  24. 7.4.5 Sinovac Biotech Recent Developments
  25. 7.5 IMBCAMS,China
  26. 7.5.1 IMBCAMS,China Company Information
  27. 7.5.2 IMBCAMS,China Business Overview
  28. 7.5.3 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  30. 7.5.5 IMBCAMS,China Recent Developments
  31. 7.6 BIBP
  32. 7.6.1 BIBP Company Information
  33. 7.6.2 BIBP Business Overview
  34. 7.6.3 BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  36. 7.6.5 BIBP Recent Developments
8 North America
  1. 8.1 North America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Type
  2. 8.1.1 North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2032)
  3. 8.1.2 North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2032)
  4. 8.1.3 North America SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2021-2032)
  5. 8.2 North America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Application
  6. 8.2.1 North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2032)
  7. 8.2.2 North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2032)
  8. 8.2.3 North America SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2021-2032)
  9. 8.3 North America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country
  10. 8.3.1 North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America SARS-Cov-2 Vaccine (Vero Cell) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size by Type
  2. 9.1.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2032)
  3. 9.1.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2032)
  4. 9.1.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2021-2032)
  5. 9.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size by Application
  6. 9.2.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2032)
  7. 9.2.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2032)
  8. 9.2.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2021-2032)
  9. 9.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country
  10. 9.3.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China SARS-Cov-2 Vaccine (Vero Cell) Market Size by Type
  2. 10.1.1 China SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2032)
  3. 10.1.2 China SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2032)
  4. 10.1.3 China SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2021-2032)
  5. 10.2 China SARS-Cov-2 Vaccine (Vero Cell) Market Size by Application
  6. 10.2.1 China SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2032)
  7. 10.2.2 China SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2032)
  8. 10.2.3 China SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia SARS-Cov-2 Vaccine (Vero Cell) Market Size by Type
  2. 11.1.1 Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2032)
  3. 11.1.2 Asia SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2032)
  4. 11.1.3 Asia SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2021-2032)
  5. 11.2 Asia SARS-Cov-2 Vaccine (Vero Cell) Market Size by Application
  6. 11.2.1 Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2032)
  7. 11.2.2 Asia SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2032)
  8. 11.2.3 Asia SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2021-2032)
  9. 11.3 Asia SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country
  10. 11.3.1 Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia SARS-Cov-2 Vaccine (Vero Cell) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Market Size by Type
  2. 12.1.1 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2021-2032)
  5. 12.2 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Market Size by Application
  6. 12.2.1 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2021-2032)
  9. 12.3 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country
  10. 12.3.1 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA SARS-Cov-2 Vaccine (Vero Cell) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 SARS-Cov-2 Vaccine (Vero Cell) Value Chain Analysis
  2. 13.1.1 SARS-Cov-2 Vaccine (Vero Cell) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 SARS-Cov-2 Vaccine (Vero Cell) Production Mode & Process
  6. 13.2 SARS-Cov-2 Vaccine (Vero Cell) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 SARS-Cov-2 Vaccine (Vero Cell) Distributors
  9. 13.2.3 SARS-Cov-2 Vaccine (Vero Cell) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst